Sergey

Sergey F. is a seasoned professional with over a decade of expertise in Business Development and Market Expansion within the biotech, healthtech, diagnostics, and regulated healthcare sectors. He has extensive experience in pricing, reimbursement, and commercial strategy across Central and Eastern Europe (CEE), and is known for successfully opening new markets and securing strategic partnerships. His career highlights include a significant role at Neomed Global, where he developed distributor networks and introduced clinical technologies across 20+ healthcare markets, and a senior position at Bene Meat Technologies, driving biotechnology innovations in the EU and Middle East. His earlier collaboration with Fresenius involved dialysis infrastructure projects in Ukraine, providing key insights into GMP-related processes. Recognized for his ability to translate complex scientific concepts into clear commercial propositions, Sergey has engaged with EU-level stakeholders to shape policy and strategy, notably contributing to the Bioeconomy Strategy 2025–2040. An EU citizen, Sergey holds a Master’s Degree in Marketing & Management and is proficient in English, Czech, and Russian.